Atlas Trials

A proof-of Concept, Randomized 3-month Study to Evaluate the Effects of Three Contraceptive Intrauterine Systems Delivering Copper and a Daily Dose of 5, 20 or 40 μg of Ulipristal Acetate (UPA)

Clinical trial NCT03230539 · UNKNOWN

Trial details

NCT number
NCT03230539
Sponsor
Population Council
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Contraception
Start date
2017-05-01
Primary completion
2018-01-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.